Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Genitourin Cancer ; 17(5): e1054-e1059, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31303559

RESUMEN

BACKGROUND: We tested for associations between socioeconomic status (SES) and adverse prostate cancer pathology in a population of African American (AA) men treated with radical prostatectomy (RP). PATIENTS AND METHODS: We retrospectively reviewed data from 2 institutions for AA men who underwent RP between 2010 and 2015. Household incomes were estimated using census tract data, and patients were stratified into income groups relative to the study population median. Pathologic outcomes after RP were assessed, including the postsurgical Cancer of the Prostate Risk Assessment (CAPRA-S) score and a definition of adverse pathology (stage ≥ pT3, Gleason score ≥ 4+3, or positive lymph nodes), and compared between income groups. RESULTS: We analyzed data of 347 AA men. Median household income was $37,954. Low-SES men had significantly higher prostate-specific antigen values (mean 10.2 vs. 7.3; P < .01) and CAPRA-S scores (mean 3.4 vs. 2.5; P < .01), more advanced pathologic stage (T3-T4 31.8% vs. 21.5%; P = .03), and higher rates of seminal vesicle invasion (17.3% vs. 8.2%; P < .01), positive surgical margins (35.3% vs. 22.1%; P < .01), and adverse pathology (41.4% vs. 30.1%; P = .03). Linear and logistic regression showed significant inverse associations of SES with CAPRA-S score (P < .01) and adverse pathology (P = .03). CONCLUSION: In a population of AA men who underwent RP, we observed an independent association of low SES with advanced stage or aggressive prostate cancer. By including only patients in a single racial demographic group, we eliminated the potential confounding effect of race on the association between SES and prostate cancer risk. These findings suggest that impoverished populations might benefit from more intensive screening and early, aggressive treatment of prostatic malignancies.


Asunto(s)
Prostatectomía/métodos , Neoplasias de la Próstata/cirugía , Negro o Afroamericano/estadística & datos numéricos , Anciano , Humanos , Modelos Logísticos , Masculino , Márgenes de Escisión , Persona de Mediana Edad , Antígeno Prostático Específico/metabolismo , Neoplasias de la Próstata/etnología , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , Estudios Retrospectivos , Medición de Riesgo , Clase Social , Análisis de Supervivencia , Población Blanca/estadística & datos numéricos
2.
Urology ; 113: e9-e10, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29288787

RESUMEN

Although iatrogenic ureteral injuries are rare, they have potentially devastating consequences for both patients and physicians, and their management remains challenging. We report a case of a 51-year-old morbidly obese (body mass index = 63) woman who suffered an iatrogenic 15-cm right ureteral avulsion during hysteroscopic biopsy. Preoperative antegrade and retrograde pyelograms demonstrated no true renal pelvis and a 3-cm blind-ending distal ureteral stump. The patient underwent a right robotic downward nephropexy, psoas hitch, lower pole calycostomy, and 11-cm appendiceal interposition. At 6 months postoperatively, renal scan demonstrated stable right renal function with no evidence of obstruction.


Asunto(s)
Histeroscopía/efectos adversos , Obesidad Mórbida , Uréter/lesiones , Enfermedades Ureterales/cirugía , Procedimientos Quirúrgicos Urológicos/métodos , Anastomosis Quirúrgica/métodos , Apéndice/cirugía , Biopsia/efectos adversos , Biopsia/métodos , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Histeroscopía/métodos , Enfermedad Iatrogénica , Puntaje de Gravedad del Traumatismo , Persona de Mediana Edad , Nefrotomía/métodos , Músculos Psoas/cirugía , Enfermedades Raras , Medición de Riesgo , Resultado del Tratamiento , Uréter/cirugía , Enfermedades Ureterales/diagnóstico por imagen , Enfermedades Ureterales/etiología , Urografía/métodos , Hemorragia Uterina/diagnóstico , Hemorragia Uterina/etiología
3.
Urology ; 100: 169-174, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27639788

RESUMEN

OBJECTIVE: To assess life expectancy and biopsy outcomes in men undergoing prostate biopsy at an academic medical center. METHODS: We analyzed men who underwent prostate biopsy at our medical center between July 2012 and June 2014. Long-term other-cause mortality risk was determined using survival tables. Indications for biopsy and biopsy outcomes were assessed, and compared among men with varying mortality risks. RESULTS: A total of 417 men underwent prostate biopsy, in whom 14-year other-cause mortality risk ranged from 9% to 74%. One hundred ninety-three men (46.3%) were considered low-mortality risk (<40% risk of 14-year mortality), 131 (31.4%) intermediate risk (41%-55% 14-year mortality), and 93 (22.3%) high risk (>55% 14-year mortality). Of the 417 patients who underwent biopsy, 149 (35.7%) were found to have prostate cancer. There was no significant difference in the rate of positive biopsies (P = .72), distribution of Gleason scores (P = .60), or percentage of positive biopsy cores (P = .74) between mortality risk groups. However, by UCSF Cancer of the Prostate Risk Assessment score, there was significant trend toward higher-risk prostate cancer in men with intermediate and high-mortality risk (P = .04). CONCLUSION: In this analysis, a large number of men with limited life expectancies underwent prostate biopsy. The majority of these men had negative biopsies or low-risk cancers, suggesting that they were unlikely to benefit from biopsy. To avoid potentially unnecessary prostate biopsies, the practitioner must give serious consideration to a patient's age and medical comorbidities before making a recommendation as to whether biopsy should be performed.


Asunto(s)
Esperanza de Vida , Neoplasias de la Próstata/complicaciones , Neoplasias de la Próstata/mortalidad , Centros Médicos Académicos , Factores de Edad , Anciano , Biopsia , Estudios de Cohortes , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Selección de Paciente , Valor Predictivo de las Pruebas , Neoplasias de la Próstata/patología , Medición de Riesgo , Tasa de Supervivencia
4.
Am J Obstet Gynecol ; 214(5): 566-71, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26519785

RESUMEN

Iatrogenic ureteral injuries, more than half of which occur during gynecologic surgery, may have devastating consequences for both patients and physicians. Gynecologists have employed various techniques such as cystoscopy, ureteral stents, and lighted ureteral stents to prevent ureteral injuries. The emergence and increasing prevalence of robotic surgery necessitates that we not only reevaluate the utility of these techniques, but also develop new ones specific for the robotic modality. In the robotic setting, the surgeon lacks tactile feedback and must rely primarily on visual cues. The use of intraureteral indocyanine green and subsequent visualization under near-infrared fluorescence appears to be a promising technique to primarily and secondarily prevent ureteral injuries during robotic gynecologic surgery.


Asunto(s)
Fluorescencia , Procedimientos Quirúrgicos Ginecológicos , Enfermedad Iatrogénica/prevención & control , Cuidados Intraoperatorios , Procedimientos Quirúrgicos Robotizados , Uréter/diagnóstico por imagen , Colorantes , Cistoscopía , Femenino , Humanos , Verde de Indocianina , Complicaciones Intraoperatorias/prevención & control , Cuidados Preoperatorios , Stents , Uréter/lesiones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA